Understanding the Risks of Investing in Vertex Pharmaceuticals, Inc (VRTX)

Vertex Pharmaceuticals, Inc’s recent filing unveils that its Director LR 2019 Benefit Trust acquired Company’s shares for reported $76021.0 on May 21 ’25. In the deal valued at $447.18 per share,170 shares were bought.

Then, SR 2019 Benefit Trust bought 170 shares, generating $76,021 in total proceeds.

Before that, ALTSHULER DAVID sold 52 shares. Vertex Pharmaceuticals, Inc shares valued at $22,084 were divested by the EVP, Chief Scientific Officer at a price of $424.69 per share. As a result of the transaction, ALTSHULER DAVID now holds 23,281 shares, worth roughly $10.38 million.

Wolfe Research downgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Peer perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Market perform”. Canaccord Genuity revised its rating on February 12, 2025. It rated VRTX as “a Hold” which previously was an “a Sell”.

Price Performance Review of VRTX

On Tuesday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 2.29% to $446.00. Over the last five days, the stock has gained 1.21%. Vertex Pharmaceuticals, Inc shares have risen nearly 10.75% since the year began. Nevertheless, the stocks have fallen -0.34% over the past one year. While a 52-week high of $519.88 was reached on 03/14/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $476.81, while 200 days put it at $467.50.

Levels Of Support And Resistance For VRTX Stock

The 24-hour chart illustrates a support level at 439.73, which if violated will result in even more drops to 433.47. On the upside, there is a resistance level at 449.87. A further resistance level may holdings at 453.74. The Relative Strength Index (RSI) on the 14-day chart is 45.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.38, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 9.26%. Stochastics %K at 55.48% indicates the stock is a holding.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.